A phase II study of gefitinib plus S-1 after gefitinib monotherapy in patients with adenocarcinoma of the lung.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 13 May 2016
At a glance
- Drugs Gefitinib (Primary) ; Gimeracil/oteracil/tegafur
- Indications Lung cancer
- Focus Therapeutic Use
- 20 Apr 2016 Status changed from recruiting to active, no longer recruiting.
- 30 Mar 2012 Planned End Date 1 Oct 2016 added as reported by University Hospital Medical Information Network - Japan record.
- 30 Mar 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.